Tigatuzumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tigatuzumab, covering 2017-09-13 to 2017-09-13. Get the full timeline:
Most recent: Clinical Trial Update: Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer [Phase 2]